Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years
- PMID: 17532152
- DOI: 10.1016/j.maturitas.2007.04.002
Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years
Comment on
-
Benefits and risks of long-term low-dose oral continuous combined hormone therapy.Maturitas. 2007 Mar 20;56(3):231-48. doi: 10.1016/j.maturitas.2006.08.004. Epub 2006 Oct 10. Maturitas. 2007. PMID: 17034966 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
